This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Siga Technologies Inc.. Active years: 2016-2025.
Company Filing History:
Years Active: 2016-2025
Title: The Innovative Mind of Gary Sweetapple: Pioneering Polymorphic Forms in Pharmaceutical Compositions
Introduction:
Gary Sweetapple, a prolific inventor based in Madison, OH (US), has left an indelible mark in the field of pharmaceutical compositions with his groundbreaking work on polymorphic forms. With an impressive portfolio of 6 patents to his name, Sweetapple has consistently pushed the boundaries of innovation in the industry.
Latest Patents:
Sweetapple's latest patents revolve around the polymorphic forms of ST-246 and methods of their preparation. These patents disclose the polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide, along with their synthesis methods and pharmaceutical compositions.
Career Highlights:
Currently associated with Siga Technologies Inc., Sweetapple continues to drive innovation within the company. His meticulous approach to research and development has led to the successful creation of novel pharmaceutical compositions that have the potential to revolutionize the industry.
Collaborations:
Sweetapple's collaborative spirit is evident in his work with esteemed coworkers such as William C Weimers and Dylan Nelson. Together, they form a dynamic team that synergizes their expertise to bring forth cutting-edge solutions in the realm of pharmaceuticals.
Conclusion:
In conclusion, Gary Sweetapple stands as a visionary inventor whose passion for exploring polymorphic forms has reshaped the landscape of pharmaceutical compositions. His dedication to innovation, coupled with his collaborative efforts, underscores his commitment to advancing the field and improving lives through groundbreaking discoveries.